Anthrax Protective Antigen-directed Antibody
- Name
- Anthrax Protective Antigen-directed Antibody
- Accession Number
- DBCAT003799
- Description
Not Available
- Drugs
Drug Drug Description Obiltoxaximab A monoclonal antibody used for prophylaxis or treatment of inhalational anthrax. Raxibacumab A monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate. - Drugs & Drug Targets
Drug Target Type Raxibacumab Protective antigen target